Related Tags >> Drug Trials Phase III New Drug Application pharmaceuticals

FDA News

Most Popular FDA Story

FDA reform advocates want trial, data transparency

June 25, 2009 — 10:35am ET | By John Carroll

Under new management from the Obama administration, the FDA is taking steps toward offering greater transparency in how it reviews drugs, offers up data on safety and reaches key conclusions on... Read more...

FDA Press Releases

FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD
FDA Provides PDUFA Target Agency Action Date For GTx's Toremifene 80 mg NDA
Former FDA Official Steven Niedelman Joins Crowell & Moring Health Care Group
Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS (raltegravir) in Adult Patients
ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration

Latest Headlines

FDA reform advocates want trial, data transparency
June 25, 2009
SkyePharma faces regulatory delay for lead drug
June 9, 2009
FDA begins move to unveil secret data
June 2, 2009
Cadence files NDA for Acetavance
May 15, 2009
Hamburg chosen as FDA chief, Sharfstein as deputy
March 12, 2009
FDA approves first new gout drug in 40 years
February 17, 2009
FDA panel narrowly votes in favor of Dyax drug
February 5, 2009
Blog: FDA pick could be between Califf, Sharfstein
February 4, 2009
Prasugrel vote will signal FDA's risk/benefit stance
February 2, 2009
FDA wants more data on Schering's Saphris
January 14, 2009
GSK unveils $300M vaccines plant; FDA recommends seizure therapy; Abbott licenses nanotech;
January 8, 2009
Personalized medicine comes into its own
January 5, 2009
FDA rejects Salix's ulcerative colitis drug
December 30, 2008
Slow-moving FDA misses deadline on Takeda drug
December 24, 2008
AMAG shares slump on new FDA letter
December 23, 2008
Amgen files for crucial denosumab approval
December 22, 2008
FDA approvals up in '08, missed deadlines abound
December 22, 2008
Diabetes drugs face higher hurdle at FDA
December 18, 2008
FDA advisers skeptical of retrospective genetic analysis
December 17, 2008
Anti-Epileptic meds issued an FDA suicide risk warning
December 17, 2008

Paid Research Reports

More Research Reports >>